NASDAQ:TRIL
Delisted

Trillium Therapeutics Inc. Stock Forecast

$18.44
+0 (+0%)
At Close: May 27, 2022
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Trillium Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Trillium Therapeutics Inc. is TRIL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Trillium Therapeutics Inc. Stock?
Trillium Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Trillium Therapeutics Inc. Stock?
Trillium Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Trillium Therapeutics Inc. Stock.

What's the current price of Trillium Therapeutics Inc. Stock?
As of the end of day on the 2022-05-27, the price of an Trillium Therapeutics Inc. (TRIL) share was $18.44.

What is the 52-week high and low for Trillium Therapeutics Inc. Stock?
The 52-week high for Trillium Therapeutics Inc. Stock is $18.49 and the 52-week low is $5.80.
Click to get the best stock tips daily for free!

About Trillium Therapeutics Inc.

Trillium Therapeutics. Trillium Therapeutics Inc., an immuno-oncology company, develops therapies for the treatment of cancer. The company’s lead program is SIRPaFc, an antibody-like fusion protein, which is in Phase I clinical trial that blocks the activity of CD47 to promote the macrophage-mediated killing of tumor cells in a range of cancers. It also develops CD200 monoclonal antibody that blocks the activity of CD200 to evade attack from the immune system. The com... TRIL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT